NCT05067257 2024-03-18
Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer
Sorrento Therapeutics, Inc.
Phase 2 Suspended
Sorrento Therapeutics, Inc.
National Cancer Institute, Naples
Fraser Health
Diamyd Inc
Janssen Pharmaceutical K.K.